Activity of daptomycin on biofilms produced on a plastic support by Staphylococcus spp

International Journal of Antimicrobial Agents
S RovetaG C Schito

Abstract

The aim of this study was to assess whether the novel lipopeptide daptomycin might be capable of disrupting or inhibiting the synthesis of biofilms produced by staphylococci. Fourteen recently isolated slime-producing methicillin-susceptible (MET-S) and methicillin-resistant (MET-R) strains (three MET-S Staphylococcus aureus, three MET-R S. aureus, three MET-S Staphylococcus epidermidis, three MET-R S. epidermidis and two vancomycin-intermediate S. aureus (VISA)) were tested. Slime formation on polystyrene plates was quantified spectrophotometrically. Daptomycin (2-64 mg/L) inhibited slime synthesis by > or =80% in MET-S strains, by 60-80% in MET-R S. aureus and by 70-95% in MET-R S. epidermidis. At 64 mg/L, biofilm synthesis decreased by 80% in the VISA isolates. Daptomycin also disrupted pre-formed biofilm: >50% breakdown of initial biofilm (5h) was observed in all strains. Disruption of mature biofilms (48 h), in terms of percentage, was more variable depending on the strain, ranging from ca. 20% in a MET-R S. epidermidis strain to almost 70% in two MET-S strains (one S. aureus and one S. epidermidis). Daptomycin at concentrations achievable during therapy promoted a statistically significant inhibition of slime synthesis (p...Continue Reading

References

Aug 1, 1989·Journal of Clinical Pathology·D J FreemanC T Keane
Jul 11, 2001·Journal of Medical Microbiology·J P O'Gara, H Humphreys
Apr 5, 2002·Clinical Microbiology Reviews·W Michael Dunne
Apr 5, 2002·Clinical Microbiology Reviews·Rodney M Donlan, J William Costerton
Oct 4, 2002·The New England Journal of Medicine·Alice S Prince
Jan 18, 2003·Lancet·Philip S Stewart
Jul 25, 2003·Antimicrobial Agents and Chemotherapy·Jared A SilvermanHoward M Shapiro
Oct 7, 2003·International Journal of Antimicrobial Agents·Anna MarcheseAnna Maria Schito
Dec 25, 2003·Antimicrobial Agents and Chemotherapy·Giovanni Di BonaventuraRaffaele Piccolomini
Apr 9, 2004·The New England Journal of Medicine·Rabih O Darouiche
Nov 17, 2004·Current Pharmaceutical Design·Kazuhiro TatedaKeizo Yamaguchi
Jan 11, 2005·Clinical Therapeutics·LilyAnn Jeu, Horatio B Fung
Feb 12, 2005·The Journal of Antimicrobial Chemotherapy·Judith N SteenbergenFrancis P Tally
Jun 24, 2005·The Journal of Antimicrobial Chemotherapy·Sarah GanderRoger Finch
Oct 13, 2005·Journal of Long-term Effects of Medical Implants·Donald C Vinh, John M Embil
Feb 1, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M J Rybak
Aug 22, 2006·American Journal of Surgery·Charles E EdmistonJonathan B Towne
Oct 17, 2006·The Journal of Antimicrobial Chemotherapy·G L French
Dec 5, 2006·Expert Review of Anti-infective Therapy·Zeina A Kanafani

❮ Previous
Next ❯

Citations

Nov 21, 2013·International Journal of Antimicrobial Agents·Darren AbbanatA Simon Lynch
Oct 10, 2008·The Journal of Antimicrobial Chemotherapy·P M Hawkey
Oct 10, 2008·The Journal of Antimicrobial Chemotherapy·R E Warren
Oct 10, 2008·The Journal of Antimicrobial Chemotherapy·David M Livermore
Jul 14, 2012·TheScientificWorldJournal·Steffen B RosslenbroichThomas F Fuchs
Jan 1, 2008·Infection and Drug Resistance·Federico PerezRobert A Bonomo
Oct 22, 2011·International Journal of Molecular Sciences·Seong-Cheol ParkKyung-Soo Hahm
Dec 18, 2009·Expert Review of Anti-infective Therapy·Olaf Burkhardt, Jan T Kielstein
Jul 16, 2013·Expert Opinion on Emerging Drugs·Adamantia Liapikou, Antoni Torres
May 11, 2010·International Journal of Antimicrobial Agents·Anne-Marie ChaftariIssam Raad
May 2, 2009·Enfermedades infecciosas y microbiología clínica·Carlos Pigrau, Benito Almirante
Apr 28, 2009·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Dmytro KhadzhynovHarm Peters
May 20, 2009·Clinical Neurology and Neurosurgery·Mayurika GhoshBruce L Gilliam
Feb 10, 2009·Médecine et maladies infectieuses·J-W Decousser, F Doucet Populaire
Aug 2, 2016·Clinical Kidney Journal·Terry King-Wing MaCheuk Chun Szeto
Oct 2, 2013·Nature Reviews. Drug Discovery·Thomas BjarnsholtNiels Høiby
Jul 2, 2009·The International Journal of Artificial Organs·Emilio G QuetglasJose Ramon Azanza
Feb 6, 2020·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Ekta Kamble, Karishma Pardesi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.